Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer

ClinicalTrials.gov ID: NCT00879086

Public ClinicalTrials.gov record NCT00879086. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study in patients with advanced breast cancer is to compare the incidence and severity of neuropathy adverse events for the two treatment groups (eribulin versus ixabepilone) using National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE version 3.0) grading.

Study identification

NCT ID
NCT00879086
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
104 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009 (Actual)
Primary completion
Apr 30, 2013 (Actual)
Completion
Apr 30, 2014 (Actual)
Last update posted
Jun 22, 2023

2009 – 2014

United States locations

U.S. sites
50
U.S. states
17
U.S. cities
42
Facility City State ZIP Site status
Northern AZ Hematology and Oncology Associates Sedona Arizona 86336 —
Healing Hands Oncology and Medical Care Hawthorne California 90250 —
University of Southern California Los Angeles California 90033 —
Comprehensive Cancer Center Palm Springs California 92262 —
Comprehensive Cancer Care Specialist of Boca Boca Raton Florida 33428 —
Robert R. Carroll, MD, PA Gainesville Florida 32605 —
Hematology Oncology Associates Lake Worth Florida 33461 —
Medical Specialists of the Palm Beaches Lake Worth Florida 33467 —
Ocala Oncology Center Ocala Florida 34471 —
Hematology Oncology Associates of Treasure Coast Port Saint Lucie Florida 34952 —
Oncology and Hematology Associates of West Broward Tamarac Florida 33321 —
Hematology Oncology Associates of Illinois Chicago Illinois 60611 —
Decatur Memorial Hospital Decatur Illinois 62526 —
Central Indiana Cancer Centers Indianapolis Indiana 46219 —
Heartland Oncology Hematology Council Bluffs Iowa 51503 —
Hematology and Oncology Specialists Marrero Louisiana 70072 —
Metairie Institute of Comprehensive Health Metairie Louisiana 70006 —
Hematology and Oncology Specialists New Orleans Louisiana 70115 —
Maryland Oncology Hematology, PA Columbia Maryland 21044 —
Washington County Hospital Hagerstown Maryland 21740 —
Josephine Ford Cancer Center Brownstown Michigan 48183 —
Henry Ford Medical Center-Fairlane Dearborn Michigan 48126 —
Henry Ford Health Systems Detroit Michigan 48202 —
Henry Ford Medical Center Farmington West Bloomfield Michigan 48322 —
Summit Medical Group Berkeley Heights New Jersey 7922 —
Joan Knechel Cancer Center Mount Arlington New Jersey 7856 —
Queens Cancer Center of Queens Hospital Jamaica New York 11432 —
Saint Vincent's Comprehensive Cancer Center New York New York 10011 —
Weil Cornell Breast Center New York New York 10065 —
Montefiore Medical Center The Bronx New York 10461 —
Charleston Hematology Oncology Associates PA Charleston North Carolina 29403 —
Cancer Center of North Carolina Raleigh North Carolina 27607 —
Northwest Cancer Specialists Rose Quarter Portland Oregon 97227 —
Northwest Cancer Specialists Hoyt Portland Oregon — —
Northwest Cancer Specialists Tualatin Oregon 97062 —
Lone Star Oncology Austin Texas 78759 —
South Texas Institute of Cancer Corpus Christi Texas 78405 —
Northwest Cancer Center Corpus Christi Texas 78410 —
Texas Oncology-Sammons Cancer Center Dallas Texas 75246 —
Texas Cancer Center at Medical City Dallas Texas — —
Texas Oncology, PA Dallas Texas — —
Texas Oncology, PA Bedford Houston Texas 76033 —
Texas Oncology, PA Houston Texas 77024 —
North Texas Regional Cancer Center Plano Texas — —
Tyler Cancer Center Tyler Texas 75702 —
Northern Utah Associates Ogden Utah 84403 —
Virginia Oncology Associates Newport News Virginia 23606 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Northwest Cancer Specialist Vancouver Vancouver Washington 98684 —
Northwest Cancer Care Specialists, P.C. Vancouver Washington 98686 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00879086, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00879086 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →